Nordic Business Report-July 13, 2006-Karo Bio AB reports 6-month operating loss of SEK64.4m
(C)1994-2006 M2 COMMUNICATIONS LTD http://www.m2.com
The Swedish pharmaceuticals developer Karo Bio AB reported on Thursday (13 July) an operating loss of SEK64.4m on net sales of SEK15.2m for the financial period January-June 2006.
Operating loss for the six-month period increased from the loss of SEK40.0m in the corresponding period in 2005, while net sales decreased from SEK47.3m.
One Swedish krona (SEK) is worth approximately 0.07 British pounds (GBP).
((Comments on this story may be sent to firstname.lastname@example.org))